Two Amgen EPO Patent Infringement Claims Upheld By Federal Appeals Court
This article was originally published in The Pink Sheet Daily
Executive Summary
In a mixed decision, the appeals court also reversed a lower court's decision that rival drug makers had infringed a different patent.